RORER BIOTECHNOLOGY has a total of 15 patent applications. Its first patent ever was published in 1986. It filed its patents most often in Japan, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are COY DAVID HOWARD, MITTENZWEI HELLMUT and CHILDRENS HOSP RES FOUNDATION.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 4 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Spain | 1 | |
#5 | Finland | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Norway | 1 | |
#8 | New Zealand | 1 | |
#9 | Philippines | 1 | |
#10 | Russian Federation | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Drohan William | 11 |
#2 | Jaye Michael | 11 |
#3 | Burgess Wilson | 11 |
#4 | Maciag Thomas | 11 |
#5 | Drohan William N | 2 |
#6 | Tong Benton D | 2 |
#7 | Jaye Michael C | 2 |
#8 | Jaye M | 1 |
#9 | Uiriamu Enu Dorohan | 1 |
#10 | Drohan W | 1 |
Publication | Filing date | Title |
---|---|---|
EP0366816A1 | Recombinant platelet-derived growth factor A-chain derived from endothelial cells | |
AU2451988A | Recombinant platelet-derived growth factor a-chain derived from endothelial cells | |
ES2005114A6 | Human endothelial cell growth factor | |
US4868113A | Recombinant DNA vector encoding human endothelial cell growth factor |